Ph.D. in Pharmacology/Master of Business Administration
The Penn State College of Medicine, Department of Pharmacology, and the School of Business Administration at Penn State Harrisburg offer a cooperative program leading to the degrees of Doctor of Philosophy (Ph.D.) to be granted by the Penn State College of Medicine, and a Master of Business Administration (M.B.A.) to be granted by Penn State Harrisburg. This concurrent degree opportunity facilitates the completion of both a pharmacology doctorate and a professional degree in business administration. The program is designed primarily for students interested in pursuing a career involving high-quality independent research and positions of management responsibility within the pharmacological community.
The concurrent programs require that the student first be admitted to the Pharmacology program. Subsequently, the student is recommended for and recommended for and recommended applies for admission to the graduate school for the applies for admission to the graduate school for the applies Penn State Harrisburg M.B.A. program.
The following are required for applicants:
Pharmacology: Completed application; Graduate Record Examination (GRE) score; a bachelor’s degree reflecting a reasonable background in zoology or biology, mathematics and chemistry; a minimum junior/senior grade point average of 3.00 and with appropriate course backgrounds; two letters of recommendation; a curriculum vitae; a description of career goals. Reading knowledge of one or two foreign languages is recommended.
M.B.A. Program: Completed graduate school application; Graduate Management Admission Test (GMAT) score; letter of recommendation from the department chair of the Pharmacology Department; evidence of profi ciency in analytic skills through college-level calculus and statistics demonstrated either by completion of courses or successful completion of a mathematics profi ciency examination approved by the program; evidence of profi ciency in microcomputer applications skills; profi ciency in writing evidenced by a score of "4" or higher on the writing assessment portion of the GMAT; profi ciency in entry-level fi nancial accounting as demonstrated by completion of college-level coursework; completion of a set of pre-program business core requirements demonstrated by completion of a minimum of six credits of advanced undergraduate work in each core areas. Each course must have been completed with a grade of B or higher within seven years prior to admission to the M.B.A program. The School of Business Administration will review the applicant’s transcripts for acceptability of the courses.
It is anticipated that most students in the concurrent programs will require additional graduate credits in order to satisfy the entry and pre-program requirements in business administration. Nine credits of course work in pharmacology may be transferred toward the M.B.A. Students must obtain a grade satisfactory to the program in order for the credits to be transferable. Nine credits of M.B.A. coursework may be transferred for credit toward the Ph.D. degree, subject to the approval of the Department of Pharmacology.
All students in the concurrent program have two advisors, one in the School of Business Administration and one from the faculty in the Department of Pharmacology. Because the concurrent program is designed to be taken in synchrony with the objective that both degrees will be earned simultaneously, students who do not demonstrate progress toward completion of both degrees may be denied continuation in the concurrent program. Such a decision will rest jointly with the faculties of the M.B.A. and the Ph.D. programs.
The Course Matrix
For more information and the latest updates on the concurrent programs, call the department of Pharmacology at 717-531-8285 or visit the web sites at:
For a list of courses, visit the web at Whitebook.
This page is not a part of the official Penn State University Bulletin.